fda approves generic glp 1 Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic Novi GLP-1 2026: Pricing From

Stephen Appezzato Key Takeaways Federal exclusion of weight-loss drugs forces Medicare GLP-1 utilization into other FDA-approved indications, even as 2024 Part D gross GLP-1 spending reached $27.5 billion across 21.8 million claims

Were honored to feature Julie Lloyd, MAOM of Noble Mediation Services and her powerful guest article on protecting your mental health through separation, divorce, and conflict resolution

Antioxidant enzymes and oxidative stress in the erythrocytes of iron deficiency anemic patients supplemented with vitamins

Hair loss is distressing but temporary and reversible, while the metabolic benefits of GLP-1 medications are substantial and immediate